108 results
8-K
CHRS
Coherus Biosciences Inc
4 Jun 24
Submission of Matters to a Vote of Security Holders
4:05pm
on April 15, 2024.
Proposal 1. The Company’s stockholders elected by a majority of votes cast each of the Class I director nominees below, Lee N
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
stock or such other ownership interests having such power only by reason of the happening of a contingency) to elect a majority of the Board of Directors
8-K
EX-99.2
gmq wc6mr
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K/A
EX-99.1
v50p po3o
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-99.2
xd6it
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
fq9un 14qnh6
12 Sep 23
Prospectus supplement for primary offering
6:04am
424B3
bmy6 0rzxy
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
f3bo9lk lcxdmz24
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
cq7syeay0 6ik6dv1
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
ha0pjan3ad8n5buj
16 Jun 23
Business combination disclosure
5:12pm
425
4guzekb75ic4ace n1
16 Jun 23
Business combination disclosure
5:11pm
425
darf3jw hw4mxyvh
16 Jun 23
Business combination disclosure
8:08am
425
836ywi1njd3d793
16 Jun 23
Business combination disclosure
7:09am
8-K
g476lrd2au7 cu
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-2.1
4gacbu5j
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am